March 04, 2021
Hispanic and Latino adults have a high prevalence of cardiovascular risk factors, but many are receiving inadequate treatment.
March 03, 2021
The American Heart Association published a special issue to discuss current research in cardiovascular disease and outcomes in women.
March 01, 2021
Investigators used MRI scans of the heart to identify whether heart injury was caused by COVID-19 infection.
February 23, 2021
New clinical practice guidelines call for lowering blood pressure levels down to 120 mmHg systolic for those with chronic kidney disease.
February 18, 2021
Once-weekly semaglutide 2.4 mg resulted in sustained reductions in weight for those who are overweight or obese, the investigators reported.
February 16, 2021
Novartis’ sacubitril/valsartan (Entresto) is now indicated for use in the treatment of chronic heart failure.
February 09, 2021
The American Heart Association’s recent scientific statement found that mental health impacts risk factors for heart disease.
Insulin resistance and type 2 diabetes were major contributors to premature coronary heart disease, according to the study results.
February 08, 2021
The American Heart Association (AHA) is urging those with heart conditions and those who are at risk for cardiovascular disease to receive the COVID-19 vaccine.
February 03, 2021
Pharmacists can help patients through education, therapy, and lifestyle modifications.
January 28, 2021
The latest Heart Disease and Stroke Statistical Update highlighted pandemic-related trends that may impact cardiovascular disease mortality for years.
A recent study examined patient characteristics and factors affecting COVID-19 mortality in individuals with diabetes.
January 22, 2021
Investigators compared outcomes among patients with COVID-19 and hypertension through modifying blood pressure medication use.
January 20, 2021
The FDA has approved vericiguat (Verquvo; Merck) for use in patients with chronic heart failure (HF) and ejection fraction less than 45%.
January 19, 2021
High blood pressure appears to accelerate a decline in cognitive performance in middle-aged and older adults, according to new research.
January 12, 2021
Results of a recent study showed that both high and low density lipoprotein cholesterol were linked to an increase risk of all-cause mortality in the general population.
January 08, 2021
The agency granted priority review to dapagliflozin (Farxiga; AstraZeneca) for the treatment of new or worsening chronic kidney disease in adults with and without type 2 diabetes.
January 05, 2021
Investigators evaluated pharmacogenetic results for statin myopathy risk to determine the clinical benefit of these testing programs.
December 17, 2020
An FDA panel voted to recommend the expanded use of sacubitril/valsartan (Entresto; Novartis).
December 01, 2020
Increased prevalence of high blood pressure may be among the “collateral damage” from isolation as a result of the COVID-19 pandemic, investigators said.
